The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting
Open accessAbstract
PURPOSE To investigate the efficacy and safety of corneal collagen cross-linking (CXL) with photoactivated riboflavin (photoactivated chromophore for infectious keratitis [PACK]-CXL) in the management of infectious keratitis with corneal melting. DESIGN Prospective clinical trial. PARTICIPANTS Forty eyes from 40 patients with advanced infectious keratitis and coexisting corneal melting. METHODS Twenty-one patients (21 eyes) underwent PACK-CXL treatment in addition to antimicrobial therapy. The control group consisted of 19 patients (19 eyes) who received only antimicrobial therapy. MAIN OUTCOME MEASURES The slit-lamp characteristics of the corneal ulceration, corrected distance visual acuity, duration until healing, and complications were documented in each group. The Mann-Whitney U test was used for statistical analysis. P values less than 0.05 were considered statistically significant. RESULTS The average time until healing was 39.76 ± 18.22 days in the PACK-CXL group and 46.05 ± 27.44 days in the control group (P = 0.68). After treatment and healing, corrected distance visual acuity was 1.64 ± 0.62 in the PACK-CXL group and 1.67 ± 0.48 in the control group (P = 0.68). The corneal ulceration's width and length was significantly bigger in the PACK-CXL group (P = 0.004 and P = 0.007). Three patients in the control group demonstrated corneal perforation; infection recurred in 1 of them. No serious complications occurred in the PACK-CXL group. CONCLUSIONS Corneal CXL with photoactivated riboflavin did not shorten the time to corneal healing; however, the complication rate was 21% in the control group, whereas there was no incidence of corneal perforation or recurrence of the infection in the PACK-CXL group. These results indicate that PACK-CXL may be an effective adjuvant therapy in the management of severe infectious keratitis associated with corneal melting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Cited by
Photoantimicrobials—are we afraid of the light?
Wainwright, M., Maisch, T., Nonell, S., Plaetzer, K., Almeida, A., Tegos, G. P., & Hamblin, M. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30268-7 · Cited by 713
Update on the Management of Infectious Keratitis
Austin, A., Lietman, T., & Rose-Nussbaumer, J. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.012 · Cited by 613
Ting, D. S. J., Ho, C. S., Deshmukh, R., Said, D. G., & Dua, H. S. (2021) · Eye · doi:10.1038/s41433-020-01339-3 · Cited by 515
Self-citationFungal keratitis: An overview of clinical and laboratory aspects
Mahmoudi, S., Masoomi, A., Ahmadikia, K., Tabatabaei, S. A., Soleimani, M., Rezaie, S., Ghahvechian, H., & Banafsheafshan, A. (2018) · Mycoses · doi:10.1111/myc.12822 · Cited by 260
Metadata
- Authors
- Said, D. G., Elalfy, M. S., Gatzioufas, Z., El-Zakzouk, E. S., Hassan, M. A., Saif, M. Y., Zaki, A. A., Dua, H. S., & Hafezi, F.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 121
- Issue
- 7
- Pages
- 1377-1382
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2125848613
- Cited by
- 216
- References
- 1
- FWCI
- 20.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting. https://app.cochat.ai/papers/10.1016/j.ophtha.2014.01.011
- The paper
- Said, D. G., Elalfy, M. S., Gatzioufas, Z., El-Zakzouk, E. S., Hassan, M. A., Saif, M. Y., Zaki, A. A., Dua, H. S., & Hafezi, F. (2014). Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting. Ophthalmology. https://doi.org/10.1016/j.ophtha.2014.01.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.